GLP1-RA Learning Series

Welcome to the GLP1-RA Learning Series

Welcome to GLP1-RA Learning Series 

The Canadian Cardiovascular Society is pleased to share the launch of an upcoming new program entitled the ‘GLP1-RA Learning Series.’ This program aims to enhance healthcare providers’ knowledge and skills to improve outcomes for high-risk patient populations through the effective integration of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into clinical practice.  

This educational series will consist of MOC Section 1 accredited webinars, followed by MOC Section 3 accredited self-assessment programs to be launched online after each session.   

Past Events:

Part 1: Bridging the Gap: Role of GLP-1 RAs in Obesity, Diabetes, and Cardiovascular Community Care 

Date: March 19, 2025 from 8:00 p.m. to 9:15 p.m ET   
Faculty: Dr. Anil Gupta, Dr. Alice Cheng, Dr. Kim Connelly, Dr. Sean Wharton     

This program has received an educational grant from Novo Nordisk. This program was developed by the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity, and balance.